JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shibata, S.
Right arrow Articles by Holland, W. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shibata, S.
Right arrow Articles by Holland, W. C.
Journal of Pharmacology And Experimental Therapeutics, Vol. 155, Issue 3, 422-427, 1967
Copyright © 1967 by American Society for Pharmacology and Experimental Therapeutics


EPINEPHRINE POTENTIATION IN ISOLATED RABBIT AORTIC STRIPS

Shoji Shibata 1, Arthur H. Briggs 1, and William C. Holland 1

1 Department of Pharmacology, University of Mississippi Medical Center, Jackson, Mississippi

A unique type of potentiation to low doses of epinephrine in isolated rabbit aortic strips is described. This potentiation has the following characteristics: 1) Potentiation of low doses of epinephrine (10-l0-10-9 M) develops after pretreatment with high doses of epinephrine (10-7-10-5 M). 2) Time (120 min) is required between the first and second application of epinephrine for full development of this potentiation. 3) Potentiation to low concentrations of epinephrine or norepinephrine is not observed in strips pretreated with high doses of norepinephrine. 4) Potentiation can be abolished by treating sensitized strips with high doses of norepinephrine but not other contractile agents such as isoproterenol, angiotensin or tyramine. 5) Reserpine-pretreated preparations do not develop potentiation to epinephrine unless pretreated with high doses of norepinephrine. 6) Potentiation to low concentrations of epinephrine can also be produced by repeated exposures to tyramine in normal preparations but not in reserpine-pretreated preparations. Although the mechanism of this effect is not clear, the possibility is suggested that it is related to a displacement or translocation of norepinephrine and the subsequent production of a metabolite or change resulting in potentiation.

Submitted on June 16, 1966
Accepted on September 26, 1966







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics.